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Objective:	  To	  determine	  if	  ethyl	  chloride	  spray	  provides	  adequate	  analgesia	  prior	  to	  injections.	  
Design:	  Systematic	  literature	  review.	  Methods:	  A	  search	  was	  conducted	  in	  both	  Pubmed	  and	  
Scopus	  using	  search	  terms	  ethyl	  chloride	  and	  injection.	  The	  Pubmed	  search	  was	  narrowed	  to	  
include	  studies	  within	  a	  10-­‐year	  publication	  range.	  Articles	  were	  excluded	  based	  on:	  population	  
age	  range,	  date	  of	  publication,	  and	  if	  ethyl	  chloride	  was	  used	  in	  conjunction	  with	  another	  
analgesic.	  There	  were	  no	  relevant	  articles	  in	  the	  Scopus	  search.	  Results:	  Franko	  O,	  Stern	  P.	  
demonstrated	  that	  there	  was	  no	  statistically	  significant	  improvement	  in	  anxiety	  or	  pain	  
perceived	  with	  ethyl	  chloride	  treatment	  as	  compared	  to	  the	  control.1	  Irkoren	  et	  al.	  found	  that	  
ethyl	  chloride	  spray	  and	  Eutectic	  Mixture	  of	  Local	  Anesthetic	  (EMLA)	  cream	  each	  significantly	  
decreased	  the	  pain	  associated	  with	  forehead	  botulinum	  toxin	  (BTX)	  injections	  when	  compared	  
to	  the	  control.2	  The	  majority	  of	  patients	  preferred	  the	  ethyl	  chloride	  spray	  over	  the	  EMLA	  
cream	  as	  an	  analgesic.2	  Moon	  et	  al.	  determined	  lidocaine	  and	  ethyl	  chloride	  are	  equally	  
effective	  methods	  for	  decreasing	  pain	  associated	  with	  injections.3	  Ethyl	  chloride	  spray	  had	  the	  
added	  benefit	  of	  a	  lack	  of	  metallic	  taste.3	  Conclusion:	  We	  cannot	  conclude	  that	  ethyl	  chloride	  
spray	  is	  an	  effective	  analgesic	  prior	  to	  injections	  in	  men	  and	  women.	  However,	  we	  do	  
recommend	  its	  use	  prior	  to	  BTX	  forehead	  injections	  and	  dorsal	  hand	  propofol	  injections	  in	  




The	  use	  of	  injections	  is	  a	  frequently	  utilized	  treatment	  and	  assessment	  modality	  
presenting	  throughout	  most,	  if	  not	  all,	  disciplines	  of	  medicine.	  According	  to	  the	  most	  recent	  
available	  data,	  there	  are	  around	  16	  billion	  injections	  performed	  each	  year.4	  From	  vaccinations	  
to	  nerve	  blocks,	  injections	  are	  utilized	  for	  the	  benefit	  of	  the	  patient,	  but	  are	  often	  associated	  
with	  reasonable	  pain	  and	  distress.	  Studies	  estimate	  that	  between	  2	  and	  20%	  of	  people	  seeking	  
medical	  attention	  experience	  injection	  anxiety.5	  This	  anxiety,	  described	  as	  an	  excessive	  fear	  in	  
response	  to	  the	  anticipation	  or	  experience	  of	  an	  injection,	  can	  become	  a	  barrier	  to	  treatment	  
and	  has	  been	  shown	  to	  increase	  the	  experience	  of	  pain.5	  Patients	  that	  could	  benefit	  from	  an	  
injection	  may	  hesitate	  to	  receive	  something	  that	  would	  be	  therapeutic.5	  Avoidance	  of	  
therapeutic	  measures	  can	  have	  a	  negative	  result	  on	  the	  patient’s	  attitude	  toward	  health	  care,	  
and	  potentially,	  their	  course	  of	  treatment.	  	  Reducing	  the	  levels	  of	  pain	  associated	  with	  an	  
injection	  is	  an	  important	  consideration	  to	  lowering	  a	  patient’s	  barriers	  to	  treatment.	  One	  of	  the	  
most	  prevalent	  analgesics	  for	  decreasing	  injection-­‐associated	  pain	  is	  ethyl	  chloride.	  
	  	  	  	  	  	  	  	   Ethyl	  chloride	  is	  a	  topical	  anesthetic	  approved	  for	  use	  in	  adults	  and	  children	  and	  is	  used	  
to	  temporarily	  control	  pain	  associated	  with	  injections,	  venipuncture,	  and	  minor	  surgical	  
procedures.	  The	  topical	  anesthetic	  is	  administered	  as	  a	  spray	  to	  intact	  skin	  prior	  to	  one	  of	  the	  
aforementioned	  procedures.	  Ethyl	  chloride	  utilizes	  vapocoolant	  properties	  to	  slow	  nerve	  
conduction	  of	  the	  C-­‐fibers	  and	  A-­‐delta	  fibers	  in	  the	  peripheral	  nervous	  system.8	  This	  property	  
slows	  conduction	  of	  the	  pain	  fibers	  to	  temporarily	  decrease	  the	  central	  nervous	  system’s	  
capacity	  to	  perceive	  pain.8	  The	  effects	  of	  the	  spray	  can	  last	  up	  to	  one	  minute,	  due	  to	  its	  rapid	  
evaporation	  time.7	  This	  property	  prevents	  prolonged	  loss	  of	  sensation	  for	  the	  patient.	  If	  the	  
procedure	  is	  not	  completed	  within	  one	  minute,	  the	  spray	  can	  be	  reapplied	  to	  intact	  skin	  
without	  adverse	  reaction.	  Side	  effects	  of	  ethyl	  chloride	  are	  rare	  and	  include	  allergic	  reaction	  
and	  temporary	  hypochromia.6	  Dyschromia	  occurs	  with	  over-­‐freezing	  of	  the	  skin;	  however,	  
proper	  use	  is	  preventative.6	  
	  	  	  	  	  	  	  	   The	  aim	  of	  this	  study	  is	  to	  compile	  the	  most	  up-­‐to-­‐date	  evidence	  to	  investigate	  whether	  
there	  is	  a	  statistically	  significant	  difference,	  as	  well	  as	  a	  clinically	  significant	  difference,	  in	  the	  




Among	  adults	  receiving	  injections,	  does	  ethyl	  chloride,	  as	  compared	  to	  a	  placebo,	  




	   An	  initial	  search	  was	  conducted	  on	  September	  6th,	  2017	  using	  the	  Pubmed	  database	  
(Figure	  1).	  A	  total	  of	  199	  studies	  were	  identified	  using	  search	  terms	  “ethyl	  chloride”	  and	  
“injection”.	  Narrowing	  the	  search	  to	  include	  studies	  within	  a	  10-­‐year	  publication	  range	  
produced	  55	  articles,	  which	  were	  screened	  for	  relevance.	  From	  these	  results,	  5	  full-­‐text	  articles	  
were	  assessed	  for	  eligibility.	  Two	  full-­‐text	  articles	  were	  excluded	  based	  on:	  population	  age	  
range,	  date	  of	  publication,	  and	  if	  ethyl	  chloride	  was	  used	  in	  conjunction	  with	  another	  analgesic.	  
The	  exclusion	  criteria	  left	  3	  articles	  that	  were	  included	  in	  the	  qualitative	  synthesis.	  An	  additional	  
search	  was	  also	  conducted	  using	  the	  database	  Scopus	  for	  additional	  peer-­‐reviewed	  literature.	  A	  
search	  using	  the	  same	  terms	  of	  “ethyl	  chloride”	  and	  “injections”	  yielded	  19	  articles.	  None	  of	  the	  
19	  articles	  were	  relevant	  as	  there	  was	  no	  discussion	  of	  ethyl	  chloride	  administration	  or	  






Study	  #1:	  Use	  and	  Effectiveness	  of	  Ethyl	  Chloride	  for	  Hand	  Injections.	  Franko	  O,	  Stern	  P.1	  
	  
Study	  Objective:	  
	  	  	  	  	  	  	  	   To	  determine	  the	  efficacy	  of	  ethyl	  chloride	  on	  a	  patient’s	  pain	  level	  and	  injection	  
associated	  anxiety	  before	  and	  after	  routine	  hand	  injections.	  
	  	  	  	  	  	  	  	   	  
Study	  Design:	  
	  	  	  	  	  	  	  	   The	  study	  begins	  with	  an	  email	  survey	  to	  all	  members	  of	  the	  American	  Society	  for	  
Surgery	  of	  the	  Hand	  (ASSH).	  Contact	  information	  was	  obtained	  through	  membership	  records	  of	  
the	  ASSH.	  All	  members	  were	  asked:	  “In	  your	  hand	  practice,	  how	  often	  do	  you	  use	  ethyl	  chloride	  
spray	  for	  analgesic	  effects	  immediately	  before	  a	  steroid	  injection	  (trigger	  finger,	  DeQuervain,	  
carpal	  tunnel,	  joint	  injections)?”	  Response	  options	  were	  Always	  (>90%),	  Often	  (67%-­‐90%),	  
Sometimes	  (33%-­‐66%),	  Rarely	  (10%-­‐32%),	  and	  Never	  (<10%).	  The	  survey	  aimed	  to	  characterize	  
each	  responding	  surgeon’s	  usage	  of	  ethyl	  chloride	  administration	  prior	  to	  injections.	  Responses	  
were	  collected	  over	  a	  two	  week	  period	  and	  reminders	  were	  sent	  to	  those	  who	  had	  not	  yet	  
responded.	  Those	  responding	  were	  analyzed	  in	  relation	  to	  their	  years	  of	  membership	  to	  the	  
ASSH,	  the	  region	  of	  the	  United	  States	  for	  which	  they	  practiced,	  as	  well	  as	  their	  type	  of	  practice	  
and	  specialty.	  
	  
Figure	  2:	  Percentage	  comparison	  of	  ethyl	  chloride	  usage	  among	  responding	  hand	  surgeons	  
based	  on	  specialty.1	  
	  
After	  completion	  of	  the	  survey,	  a	  prospective,	  randomized	  study	  was	  completed	  to	  
evaluate	  the	  benefit	  of	  administering	  ethyl	  chloride	  compared	  to	  no-­‐spray	  on	  the	  patient’s	  
perceived	  pain	  and	  anxiety	  through	  a	  questionnaire	  completed	  before	  and	  after	  the	  injection	  
administration.	  Participants	  were	  included	  in	  the	  study	  if	  they	  were	  receiving	  a	  routine	  injection	  
for	  trigger	  finger,	  DeQuervain	  tenosynovitis,	  first	  carpometacarpal	  joint	  osteoarthritis,	  or	  carpal	  
tunnel	  syndrome.	  Patients	  were	  excluded	  if	  they	  were	  unable	  to	  complete	  an	  English	  survey	  or	  
requested	  ethyl	  chloride	  prior	  to	  an	  injection.	  Using	  either	  ethyl	  chloride	  or	  no	  spray	  in	  
alternating	  months	  was	  utilized	  for	  the	  randomization	  of	  a	  patient’s	  treatment.	  Informed	  
consent	  was	  obtained	  for	  all	  patients	  prior	  to	  each	  procedure.	  
	  	  	  	  	  	  	  After	  consenting	  to	  study	  enrollment,	  each	  patient	  completed	  a	  questionnaire	  using	  
an	  11-­‐point	  Likert	  scale	  ranging	  from	  “none”	  to	  “extreme”	  for	  three	  questions.	  The	  questions	  
are	  as	  follows:	  (1)	  How	  painful	  do	  you	  think	  it	  will	  be?,	  (2)	  How	  painful	  will	  it	  be	  1	  minute	  after	  
the	  injection?,	  and	  (3)	  How	  nervous	  are	  you	  about	  the	  injection?	  A	  fourth	  yes	  or	  no	  question	  
was	  asked	  not	  using	  the	  scale:	  (4)	  Have	  you	  had	  a	  hand	  injection	  before?...	  and	  if	  so,	  was	  ethyl	  
chloride/	  freeze	  spray	  used?	  
	  	  	  	  	  	  	  	   The	  procedure	  was	  performed	  at	  two	  different	  healthcare	  institutions	  with	  parallel	  
treatment	  regimens	  performed	  by	  the	  same	  surgeon.	  Aseptic	  preparation	  was	  performed	  with	  
alcohol	  swabs,	  and	  if	  in	  the	  spray	  group,	  ethyl	  chloride	  was	  administered	  over	  the	  injection	  site	  
for	  7-­‐10	  seconds.	  Then	  for	  both	  groups	  a	  27-­‐gauge	  needle	  was	  inserted	  with	  the	  surgeons	  
customary,	  consistent	  technique.	  For	  all	  patients,	  the	  same	  1:1	  ratio	  of	  a	  combination	  of	  1%	  
lidocaine	  and	  4mg/ml	  dexamethasone	  was	  utilized	  with	  1mL	  utilized	  for	  trigger	  finger	  or	  thumb	  
base	  joint	  injections	  and	  2mL	  for	  a	  DeQuervain’s	  tenosynovitis	  or	  carpal	  tunnel	  syndrome.	  
	  	  	  	  	  	  	  	   One	  minute	  after	  the	  procedure,	  an	  additional	  four	  item	  questionnaire	  was	  completed	  
asking	  participants	  to	  report	  their	  pain	  on	  a	  scale	  of	  1	  to	  10.	  The	  questions	  asked	  were	  for	  the	  
actual	  needle	  pain,	  the	  actual	  pain	  from	  the	  medication,	  the	  actual	  pain	  one	  minute	  after	  the	  
injection,	  and	  their	  overall	  anxiety	  related	  to	  the	  procedure.	  
	  	  	  	  	  	  	  	   Using	  statistical	  analysis,	  it	  was	  determined	  that	  having	  75	  participants	  in	  the	  ethyl	  
chloride	  spray	  group	  and	  75	  participants	  in	  the	  no	  spray	  group	  would	  be	  needed	  to	  have	  
adequate	  power	  to	  draw	  conclusions	  about	  their	  differences.	  The	  Mann-­‐Whitney	  U	  test	  was	  
implemented	  to	  compare	  the	  differences	  between	  the	  two	  groups	  based	  on	  the	  different	  
patient’s	  answers	  for	  pain	  before	  the	  injection,	  pain	  after	  the	  injection,	  pain	  after	  injection	  after	  
a	  minute,	  and	  their	  nervousness	  before	  the	  injection.	  Additional	  analysis	  was	  also	  obtained	  by	  
subgroups	  for	  sex,	  high	  anxiety,	  or	  those	  with	  high	  levels	  of	  anticipated	  pain.	  There	  were	  16	  
comparisons	  made	  and	  a	  Bonferroni	  correction,	  a	  statistical	  method	  to	  overcome	  multiple	  
comparisons,	  yielded	  an	  alpha	  level	  of	  0.003.	  
	  
Study	  Results:	  
	  	  	  	  	  	  	  	   A	  response	  rate	  of	  73%	  was	  obtained	  for	  the	  email	  survey	  from	  2,083	  members	  of	  the	  
American	  Society	  for	  Surgery	  of	  the	  Hand.	  59%	  reported	  they	  always	  or	  often	  used	  ethyl	  
chloride,	  while	  24%	  never	  utilized	  the	  spray.	  Experienced	  surgeons	  were	  considered	  less	  likely	  
to	  use	  ethyl	  chloride	  with	  only	  35%	  reporting	  utilizing	  it	  routinely	  compared	  with	  66%	  of	  
younger	  surgeons.	  No	  association	  for	  ethyl	  chloride	  usage	  was	  noted	  based	  on	  region	  or	  type	  of	  
practice.	  A	  statistically	  significant	  result	  with	  a	  p-­‐value	  <0.05	  was	  found	  for	  decreasing	  use	  of	  
ethyl	  chloride	  and	  increased	  years	  of	  practice	  as	  well	  as	  decreasing	  usage	  of	  ethyl	  chloride	  for	  
plastic,	  orthopedic,	  and	  general	  surgeons.	  Of	  the	  151	  patients	  that	  were	  studied,	  half	  received	  
ethyl	  chloride	  administration	  with	  the	  other	  half	  not	  receiving	  a	  spray.	  The	  results	  showed	  
equivalence	  in	  the	  questionnaire	  for	  injection	  pain,	  pain	  after	  1	  minute,	  and	  overall	  anxiety.	  A	  
Pearson	  test	  was	  utilized	  to	  demonstrate	  the	  pain	  from	  the	  injected	  anesthetic	  and	  post-­‐
injection	  pain	  were	  highly	  correlated	  (r=	  0.073)	  and	  a	  mean	  of	  their	  values	  was	  utilized	  to	  show	  
injection	  pain.	  There	  was	  no	  difference	  throughout	  the	  overall	  population	  studied	  for	  
anticipated	  versus	  actual	  pain	  and	  anxiety.	  However,	  there	  was	  a	  reduction	  in	  post-­‐injection	  
pain	  in	  those	  anticipating	  high	  levels	  of	  pain	  before	  the	  injection	  and	  in	  females	  for	  post-­‐
injection	  pain.	  No	  subgroup	  showed	  statistically	  significant	  improvement	  in	  anxiety	  or	  pain	  
perceived	  with	  ethyl	  chloride	  treatment.	  	  
	  
Study	  Critique:	  
	  	  	  	  	  	  	  	   A	  major	  strength	  of	  this	  study	  was	  the	  stated	  degree	  of	  patient	  randomization	  to	  initial	  
treatment.	  Patients	  were	  block-­‐randomized	  in	  groups	  of	  3	  before	  enrollment.	  This	  was	  
completed	  through	  simple	  randomization	  with	  a	  computerized	  random	  number	  generator	  and	  
sealed	  envelopes.	  For	  further	  privacy	  protection,	  the	  order	  was	  kept	  in	  sealed,	  opaque	  
envelopes	  and	  revealed	  with	  each	  patient	  enrollment.	  An	  additional	  strength	  of	  this	  study	  is	  its	  
comparison	  of	  similar,	  commonly	  used,	  and	  affordable	  forms	  of	  topical	  analgesia.	  These	  choices	  
for	  study	  are	  especially	  beneficial	  as	  they	  are	  likely	  to	  be	  applicable	  to	  a	  variety	  of	  clinical	  
settings.	  	  
A	  major	  critique	  of	  this	  study	  is	  that	  patients	  that	  requested	  ethyl	  chloride	  were	  
removed	  from	  the	  study.	  This	  was	  done	  to	  eliminate	  bias,	  but	  also	  removes	  an	  entire	  patient	  
population	  that	  had	  presumably	  received	  enough	  prior	  benefit	  from	  ethyl	  chloride	  to	  request	  
its	  administration	  again.	  It	  was	  not	  stated	  whether	  the	  study	  kept	  or	  removed	  patients	  that	  
similarly	  requested	  to	  not	  have	  ethyl	  chloride	  administration.	  The	  study	  is	  additionally	  limited	  
by	  its	  focus	  only	  on	  patient	  populations	  receiving	  hand	  injections.	  This	  is	  a	  highly	  specific	  and	  
unique	  anatomic	  region	  that	  could	  limit	  the	  ability	  to	  extrapolate	  to	  other	  areas	  and	  types	  of	  
injections.	  Additionally,	  the	  paper	  admittedly	  neglects	  to	  consider	  factors	  such	  as	  anxiety	  levels	  
and	  female	  menstruation	  which	  are	  known	  to	  alter	  a	  patient’s	  perception	  of	  pain.	  Altered	  
perceptions	  of	  pain	  have	  the	  potential	  to	  skew	  the	  final	  results.	  Furthermore,	  the	  study	  did	  not	  
use	  a	  placebo.	  Without	  a	  placebo,	  there	  was	  no	  blinding	  to	  the	  patient’s	  treatment,	  which	  can	  	  
create	  bias	  for	  accurately	  reporting	  pain.	  Patient’s	  expectations	  of	  treatment	  and	  their	  efficacy	  
can	  influence	  the	  expected	  result	  in	  terms	  of	  benefit	  and	  pain	  perception.	  If	  a	  patient	  is	  
receiving	  an	  analgesia	  they	  have	  not	  previously	  found	  beneficial,	  they	  are	  more	  likely	  to	  expect	  
a	  worse	  outcome	  than	  they	  would	  be	  with	  a	  novel	  or	  previously	  beneficial	  analgesia	  Finally,	  the	  
author’s	  of	  this	  paper	  did	  not	  specifically	  declare	  the	  source	  of	  study	  funding	  or	  any	  potential	  
conflicts	  of	  interest.	  	  
	  
Study	  #2:	  A	  Clinical	  Comparison	  of	  EMLA	  Cream	  and	  Ethyl	  Chloride	  Spray	  Application	  for	  Pain	  
Relief	  of	  Forehead	  BTX	  Injection.	  Irkoren	  et	  al.2	  	  
	  
Study	  Objective	  
	   To	  determine	  the	  efficacy	  of	  EMLA	  cream	  and	  ethyl	  chloride	  spray	  application	  for	  
analgesia	  prior	  to	  BTX	  injection.	  
	  
Study	  Design	  
	   This	  was	  a	  prospective,	  randomized	  study	  that	  consisted	  of	  45	  females	  who	  volunteered	  
to	  receive	  forehead	  injections	  of	  BTX	  A	  for	  reduction	  of	  wrinkles.	  Exclusion	  criteria	  included	  
patients	  who	  were	  taking	  analgesics	  or	  anxiolytic	  drugs,	  and	  individuals	  with	  known	  allergies	  to	  
the	  study	  medications.	  Before	  study	  enrollment,	  simple	  randomization,	  using	  a	  computer	  
random	  number	  generator,	  was	  used	  to	  block-­‐randomize	  patients	  into	  three	  groups.	  The	  
randomized	  order	  was	  kept	  in	  sealed	  opaque	  envelopes	  and	  revealed	  upon	  patient	  enrollment.	  
	   The	  first	  group	  included	  15	  females	  between	  ages	  35	  and	  60	  with	  an	  average	  age	  of	  
46.73	  +/-­‐	  8.85	  years.	  These	  women	  received	  ethyl	  chloride	  spray	  (Chlorethan	  100	  mL,	  ethyl	  
chloride	  cooling	  aerosol	  spray)	  on	  one	  side	  of	  the	  forehead;	  the	  opposite	  side	  served	  as	  the	  
control.	  The	  second	  group	  of	  15	  females	  had	  an	  average	  age	  of	  48.53	  +/-­‐	  9.04	  years	  with	  a	  
range	  of	  36	  to	  64	  years.	  In	  this	  group,	  topical	  anesthetic	  cream	  (EMLA	  cream	  5%	  25	  g	  lidocaine,	  
25	  g	  prilocaine;	  Astra	  Zeneca,	  London,	  UK)	  was	  applied	  to	  one	  side	  of	  the	  forehead	  while	  the	  
other	  side	  served	  as	  a	  control.	  The	  last	  group	  of	  15	  females	  had	  an	  average	  age	  of	  49.60	  +/-­‐	  
8.71	  years	  with	  a	  range	  of	  37	  to	  66	  years.	  On	  one	  side	  of	  the	  forehead	  the	  ethyl	  chloride	  spray	  
was	  used	  and	  on	  the	  other	  side,	  topical	  anesthetic	  cream	  was	  applied.	  
EMLA	  cream	  was	  applied	  45	  minutes	  prior	  to	  injection	  of	  BTX.	  Ethyl	  chloride	  was	  
sprayed	  on	  the	  injection	  sites	  for	  4	  to	  8	  seconds	  or	  at	  the	  first	  sign	  of	  skin	  blanching.	  Gauze	  was	  
used	  to	  shield	  the	  patients’	  eyes	  from	  the	  ethyl	  chloride	  spray.	  BTX	  was	  diluted	  with	  4mL	  of	  
0.9%	  sodium	  chloride	  so	  that	  0.1mL	  contained	  2.5	  U	  of	  BTX.	  The	  skin	  was	  sterilized	  with	  alcohol	  
before	  patients	  had	  four	  0.1mL	  injections	  of	  2.5	  U	  of	  BTX	  (maximum	  10U)	  in	  their	  forehead	  
according	  to	  the	  clinical	  features	  of	  the	  patients.	  A	  30-­‐gauge	  disposable	  needle	  was	  used	  for	  
injections,	  and	  one	  doctor	  performed	  all	  injections	  to	  decrease	  variability.	  
Pain	  was	  assessed	  using	  the	  visual	  analog	  scale	  (VAS).	  Each	  subject	  was	  informed	  on	  
how	  to	  use	  the	  VAS	  prior	  to	  scoring.	  Patients	  were	  shown	  a	  10-­‐point	  scale	  in	  which	  they	  were	  
to	  rate	  their	  pain	  on	  a	  scale	  of	  1	  to	  10,	  1	  representing	  no	  pain	  and	  10	  representing	  the	  worst	  
pain	  imaginable.	  Participants	  in	  Group	  3	  were	  requested	  to	  determine	  which	  method	  of	  
analgesia	  they	  preferred,	  the	  EMLA	  cream	  or	  ethyl	  chloride	  spray.	  	  
	  
Study	  Results	  
	   In	  group	  1,	  comparing	  ethyl	  chloride	  and	  the	  control,	  the	  average	  pain	  score	  for	  ethyl	  
chloride	  was	  3.20	  +/-­‐	  1.20	  with	  a	  range	  of	  1-­‐5.	  The	  average	  pain	  score	  for	  the	  control	  was	  7.26	  
+/-­‐	  1.94	  (range,	  4-­‐10).	  In	  group	  2,	  comparing	  EMLA	  cream	  and	  the	  control,	  the	  average	  pain	  
score	  for	  EMLA	  cream	  was	  4.20	  +/-­‐	  1.37	  (range,	  2-­‐7).	  The	  average	  pain	  score	  for	  the	  control	  was	  
7.66	  +/-­‐	  1.54	  (range,	  5-­‐10).	  Group	  3’s	  average	  pain	  score	  using	  the	  EMLA	  cream	  and	  the	  ethyl	  
chloride	  was	  6.80	  +/-­‐	  1.37	  (range,	  4-­‐9)	  and	  2.93	  +/-­‐	  1.03	  (range,	  1-­‐5),	  respectively.	  Pain	  relief	  
scores	  for	  group	  1	  and	  2	  were	  determined	  by	  subtracting	  the	  pain	  score	  of	  the	  anesthetized	  
side	  from	  the	  pain	  score	  of	  the	  control	  side	  for	  each	  patient.	  Group	  1	  and	  group	  2	  pain	  relief	  
scores	  were	  4.06	  +/-­‐	  1.79	  and	  3.46	  +/-­‐	  1.35,	  respectively.	  
	   This	  study	  showed	  that	  ethyl	  chloride	  and	  EMLA	  cream	  are	  effective	  at	  reducing	  pain	  
with	  local	  injections.	  Both	  the	  ethyl	  chloride	  group	  and	  EMLA	  cream,	  (group	  1	  and	  group	  2,	  
respectively)	  had	  a	  statistically	  significant	  reduction	  in	  pain	  as	  compared	  to	  the	  control	  
(p<0.05).	  Pain	  relief	  scores	  were	  higher	  for	  group	  1	  than	  group	  2,	  indicating	  a	  greater	  reduction	  
in	  pain	  with	  the	  use	  of	  ethyl	  chloride.	  Ethyl	  chloride	  was	  more	  effective	  than	  EMLA	  cream	  at	  
reduction	  in	  pain	  overall.	  Patients	  in	  group	  3	  rated	  pain	  lower	  with	  use	  of	  ethyl	  chloride	  as	  
compared	  to	  use	  of	  the	  EMLA	  cream,	  and	  results	  were	  statistically	  significant	  (p<	  0.05).	  Most	  
patients	  preferred	  the	  ethyl	  chloride	  spray	  over	  the	  EMLA	  cream.	  This	  study	  determined	  that	  
skin	  cooling	  ethyl	  chloride	  spray	  significantly	  decreased	  the	  pain	  associated	  with	  forehead	  BTX	  
injections.	  	  
	  
Study	  Critique	  	  
	   This	  study	  chose	  to	  randomize	  the	  participants	  into	  one	  of	  three	  study	  groups.	  
Randomization	  was	  performed	  using	  a	  computer	  random	  number	  generator	  and	  concealed,	  
until	  patient	  enrollment,	  using	  sealed	  envelopes.	  Randomization	  is	  a	  strength	  of	  this	  study	  
because	  it	  helps	  to	  minimize	  bias.	  
The	  two	  major	  limitations	  of	  the	  study	  were:	  a	  small,	  female	  only	  study	  population	  and	  
lack	  of	  placebo.	  This	  study	  population	  was	  small,	  with	  45	  participants,	  and	  included	  only	  
females.	  A	  larger	  sample	  size	  which	  includes	  men,	  would	  be	  a	  more	  accurate	  representative	  of	  
the	  general	  population	  and	  would	  increase	  confidence	  in	  applying	  results	  of	  the	  study	  to	  
patients	  in	  real	  practices.	  The	  study	  could	  not	  replicate	  the	  cooling	  effect	  of	  the	  ethyl	  chloride	  
which	  prevented	  them	  from	  using	  a	  placebo.	  Without	  a	  placebo,	  patients	  were	  not	  blinded	  and	  
were	  aware	  of	  which	  side	  of	  their	  forehead	  had	  treatment	  and	  which	  was	  the	  control.	  This	  
could	  create	  bias	  in	  reporting	  pain.	  Participants	  who	  want	  the	  treatment	  to	  work	  may	  report	  
lower	  pain	  scores	  when	  in	  fact	  there	  is	  no	  difference	  between	  the	  treatment	  or	  control.	  This	  
issue	  also	  correlates	  with	  the	  study	  using	  subjective	  data	  to	  score	  pain	  rather	  than	  objective	  
data.	  Each	  patient	  has	  a	  different	  pain	  threshold	  and	  may	  report	  pain	  differently	  on	  a	  
numbered	  scale.	  This	  could	  affect	  true	  pain	  score	  and	  thus,	  results	  of	  the	  study.	  The	  authors	  did	  
not	  declare	  conflicts	  of	  study	  or	  sources	  of	  funding.	  	  
	  
Study	  #3:	  Preventive	  effect	  of	  a	  vapocoolant	  spray	  on	  propofol-­‐induced	  pain:	  a	  prospective,	  
double-­‐blind,	  randomized	  study.	  Moon	  et	  al.3	  	  
	  
Study	  Objective	  
	   To	  compare	  the	  effect	  of	  ethyl	  chloride	  spray	  to	  lidocaine	  as	  a	  pre-­‐treatment	  for	  
propofol	  injection	  pain.	  	  
	  
Study	  Design	  
This	  prospective,	  double-­‐blind,	  randomized	  study	  included	  90	  American	  Society	  of	  
Anesthesiologists	  (ASA)	  physical	  status	  I	  or	  II	  females,	  aged	  20-­‐65	  years,	  scheduled	  for	  elective	  
gynecological	  hysteroscopy	  via	  ambulatory	  surgical	  care	  at	  Seoul	  Saint	  Mary’s	  Hospital	  in	  South	  
Korea.	  Exclusion	  criteria	  consisted	  of	  a	  history	  of	  allergy	  to	  the	  study	  drug,	  history	  of	  a	  
suspicious	  or	  known	  difficult	  airway,	  peripheral	  vascular	  disease,	  chronic	  pain	  syndrome,	  use	  of	  
an	  analgesic	  or	  topical	  anesthetic	  within	  24	  hours	  of	  surgery,	  psychiatric	  history,	  history	  of	  cold	  
intolerance,	  abnormal	  upper	  arm	  sensations,	  infection	  at	  the	  injection	  site,	  body	  mass	  index	  
>35	  kg/m2,	  pregnancy,	  or	  breastfeeding.	  
	   Participants	  were	  randomized	  into	  three	  groups	  using	  computer-­‐generated	  codes	  sealed	  
in	  opaque	  envelopes.	  The	  groups	  were:	  group	  V	  (vapocoolant	  spray),	  group	  L	  (lidocaine),	  or	  
group	  C	  (control).	  Before	  the	  start	  of	  the	  study,	  participants	  assessed	  their	  pain	  level	  using	  a	  
visual	  analogue	  scale	  (VAS)	  where	  0	  cm=	  no	  pain	  and	  10	  cm	  =	  worst	  pain	  imaginable.	  A	  20-­‐
gauge	  angiocatheter	  was	  inserted	  into	  the	  dorsum	  of	  the	  participant's	  non-­‐dominant	  hand	  and	  
ringer’s	  lactate	  solution,	  at	  a	  rate	  of	  10	  ml/min,	  was	  attached.	  Preoperative	  medication	  was	  
omitted.	  Electrocardiogram,	  non-­‐invasive	  blood	  pressure,	  heart	  rate,	  pulse	  oximetry,	  and	  
bispectral	  index	  monitor	  were	  attached	  in	  the	  operating	  room.	  Operating	  room	  temperature	  
was	  kept	  at	  25°C.	  
	   Two	  placebos	  were	  used:	  1%	  lidocaine	  (0.05	  ml/kg)	  vs.	  the	  same	  amount	  of	  normal	  
saline	  and	  vapocoolant	  spray	  vs.	  a	  placebo	  spray.	  The	  vapocoolant	  spray	  was	  Walter	  Ritter	  
GmbH	  &	  Co.,	  Hamburg,	  Germany	  ethyl	  chloride	  spray,	  and	  the	  placebo	  spray	  was	  Evian	  Eau	  
Minerale	  Naturelle.	  Labels	  on	  syringes	  were	  changed	  so	  contents	  could	  not	  be	  identified	  by	  
participants,	  and	  sprays	  were	  masked	  with	  opaque	  paper.	  	  
	   In	  the	  operating	  room,	  maintenance	  fluid	  was	  discontinued.	  With	  the	  participant	  in	  
supine	  position,	  a	  blinded	  partition	  was	  set	  between	  the	  upper	  arm	  where	  the	  propofol	  would	  
be	  injected	  and	  the	  investigator,	  who	  stood	  at	  the	  head	  of	  the	  participant.	  Participants	  were	  
asked	  to	  focus	  on	  the	  propofol	  injection	  pain	  “after	  the	  tourniquet	  was	  released”.	  A	  nurse	  who	  
did	  not	  participate	  in	  the	  assessment,	  opened	  the	  envelope	  assigned	  to	  each	  participant	  and	  
then,	  performed	  the	  study	  process	  behind	  the	  blinded	  partition.	  This	  allowed	  blinding	  of	  both	  
the	  participant	  and	  the	  investigator.	  	  
	   For	  group	  V,	  an	  automated	  blood	  pressure	  cuff	  was	  applied	  10-­‐15	  cm	  proximal	  to	  the	  
intravenous	  access	  point	  and	  inflated	  at	  50	  mmHg	  for	  venous	  occlusion.	  Normal	  saline	  was	  
injected	  as	  a	  placebo	  for	  lidocaine.	  One	  minute	  later,	  the	  propofol	  injection	  site	  was	  sprayed	  
with	  ethyl	  chloride	  spray,	  30	  cm	  from	  arm	  for	  5	  seconds.	  In	  group	  L,	  venous	  occlusion	  was	  
performed	  the	  same	  way	  as	  group	  V	  and	  lidocaine	  was	  injected.	  After	  one	  minute,	  the	  propofol	  
injection	  site	  was	  sprayed	  with	  the	  placebo	  spray	  in	  the	  same	  way.	  Group	  C	  methods	  were	  the	  
same	  as	  group	  V	  and	  L	  except	  placebo	  was	  used	  for	  both	  the	  injection	  and	  spray.	  To	  prevent	  
unblinding	  due	  to	  differences	  in	  sound,	  both	  vapocoolant	  and	  placebo	  sprays	  were	  used	  at	  the	  
same	  time	  with	  the	  assigned	  one	  targeted	  to	  the	  propofol	  injection	  site	  and	  the	  other	  targeted	  
to	  the	  open	  air.	  
	   Immediately	  after	  finishing	  the	  methods	  described	  above,	  the	  tourniquet	  was	  released	  
and	  0.5	  mg/kg	  of	  propofol-­‐medium-­‐chain	  triglyceride/long-­‐chain	  triglyceride	  (10	  mg/ml	  
ampule;	  Fresenius,	  Ankara,	  Turkey)	  was	  injected	  for	  5	  seconds.	  Blinded	  investigators	  assessed	  
the	  participant’s	  VAS	  pain	  score	  and	  occurrence	  of	  metallic	  taste	  (yes	  or	  no).	  After	  assessment	  
completion,	  Fentanyl	  (1	  µg/kg)	  was	  injected	  and	  2	  mg/kg	  of	  propofol	  was	  administered	  to	  
complete	  anesthetic	  induction.	  A	  laryngeal	  mask	  airway	  was	  inserted	  after	  unconsciousness.	  
Anesthesia	  was	  maintained	  with	  1.5–2.5%	  sevoflurane	  in	  a	  50%	  oxygen/air	  mixture.	  
	   Inhaled	  anesthetics	  were	  discontinued	  after	  surgery.	  The	  laryngeal	  mask	  airway	  was	  
removed,	  and	  participants	  were	  moved	  to	  the	  post	  anesthesia	  care	  unit	  (PACU)	  once	  they	  
regained	  consciousness	  and	  full	  muscle	  strength.	  After	  recovery,	  participants	  rated	  their	  level	  of	  
satisfaction	  with	  the	  methods	  used	  to	  prevent	  propofol	  injection	  pain	  using	  a	  five-­‐point	  scale	  
(5:	  strongly	  satisfied,	  4:	  satisfied,	  3:	  undecided,	  2:	  dissatisfied,	  and	  1:	  strongly	  dissatisfied).	  The	  




Table	  1.	  Participants’	  characteristics.3	  	  	  
	   Group	  V	  (n	  =	  30)	   Group	  L	  (n	  =	  30)	   Group	  C	  (n	  =	  30)	  
Age	  (years)	   37.6	  (9.9)	   39.9	  (9.4)	   41.3	  (12.5)	  
Weight	  (kg)	   55.9	  (8.6)	   57.7	  (9.3)	   55.8	  (7.3)	  
Height	  (cm)	   159.5	  (6.0)	   162.2	  (5.9)	   159.6	  (6.8)	  
ASA	  I/	  II	   27/3	   24/6	   23/7	  
	  
	   Of	  the	  90	  people	  enrolled,	  no	  participants	  dropped	  out	  of	  the	  study	  (Figure	  3).3	  Study	  
reported	  no	  significant	  differences	  in	  participant	  characteristics	  between	  the	  groups	  (Table	  1).3	  
	  
	  
Figure	  3.	  CONSORT	  flow	  diagram	  demonstrating	  the	  distribution	  of	  participants.3	  	  
	  
There	  was	  significantly	  lower	  pain	  from	  the	  propofol	  injection	  in	  groups	  V	  and	  L	  than	  in	  
group	  C	  (p	  <	  0.001).	  Group	  V’s,	  L’s,	  and	  C’s	  average	  pain	  intensity	  scores	  were	  0.5,	  0.5,	  and	  5,	  
respectively	  (p	  <	  0.001).	  Although	  the	  pain	  score	  for	  group	  V	  ranged	  from	  0	  to	  2.25	  and	  group	  
L’s	  pain	  score	  ranged	  from	  0	  to	  1,	  there	  was	  no	  significant	  difference	  in	  pain	  intensity	  between	  
the	  two	  groups	  (p	  =	  0.413).	  	  	  
Participants	  in	  group	  V	  and	  C	  did	  not	  report	  metallic	  taste.	  Of	  the	  30	  people	  in	  group	  L,	  
23%	  reported	  metallic	  taste.	  Group	  L	  had	  a	  statistically	  significant	  increase	  in	  the	  incidences	  of	  
metallic	  taste	  when	  compared	  to	  Group	  V	  and	  C	  (p	  <	  0.001).	  There	  was	  no	  difference	  between	  
group	  V	  and	  C.	  	  
Satisfaction	  scores	  for	  each	  group	  were	  assessed	  and	  showed	  that	  participants	  in	  groups	  
V	  and	  L	  were	  more	  satisfied	  with	  prevention	  of	  propofol	  induced	  pain	  than	  those	  in	  group	  C	  (p<	  
0.001).	  The	  average	  satisfaction	  score	  for	  group	  V	  was	  5	  with	  a	  range	  of	  4	  to	  5.	  The	  average	  
score	  for	  group	  L	  and	  C	  were	  4	  (3.75-­‐5)	  and	  2	  (2-­‐3),	  respectively.	  There	  was	  no	  significant	  
difference	  between	  group	  V	  and	  L	  (p=0.012).	  Redness,	  swelling,	  itching,	  or	  injury	  from	  cold	  was	  
not	  observed	  at	  the	  propofol	  injection	  site.	  
The	  study	  found	  that	  lidocaine	  and	  ethyl	  chloride	  are	  equally	  effective	  methods	  for	  
decreasing	  pain	  associated	  with	  injections.	  Participants	  in	  the	  study	  reported	  lower	  pain	  scores	  
and	  greater	  comfort	  in	  groups	  that	  used	  lidocaine	  or	  ethyl	  chloride.	  The	  ethyl	  chloride	  group	  
(group	  V)	  had	  the	  benefit	  of	  a	  lack	  of	  metallic	  taste.	  	  
	  
Study	  Critique	  	  
	   The	  strengths	  of	  this	  study	  include:	  randomization	  of	  participants	  into	  one	  of	  three	  
study	  groups,	  blinding	  of	  participants	  and	  investigators	  to	  treatment	  allocation,	  and	  
maintenance	  of	  blinding	  to	  treatment	  via	  placebos.	  As	  stated	  previously,	  randomization	  of	  
participants	  limits	  biases	  within	  the	  study	  by	  distributing	  lurking	  variables	  at	  chance	  levels	  
across	  treatment	  groups.	  The	  blinding	  of	  participants	  and	  investigators	  to	  the	  treatment	  
allocation	  (vapocoolant	  spray,	  lidocaine,	  or	  control)	  was	  ensured	  by	  sealing	  the	  computer	  
randomized	  numbers	  in	  envelopes	  which	  were	  opened	  by	  a	  nurse	  not	  participating	  in	  the	  study.	  
The	  investigators	  stood	  behind	  a	  curtain	  as	  the	  treatment	  was	  carried	  out	  by	  the	  nurse.	  
Placebos	  were	  used	  for	  the	  vapocoolant	  spray	  and	  the	  lidocaine	  which	  further	  ensured	  blinding	  
of	  participants.	  For	  the	  vapocoolant	  spray,	  the	  investigators	  used	  Evian	  Eau	  Minerale	  Naturelle,	  
a	  pure	  water	  spray	  of	  approximately	  the	  same	  size	  as	  the	  vapocoolant	  spray,	  and	  for	  the	  
lidocaine,	  investigators	  used	  normal	  saline.	  Since	  each	  participant	  received	  an	  injection	  and	  a	  
spray,	  they	  stayed	  blinded	  to	  the	  actual	  treatment	  used	  (vapocoolant	  spray	  vs	  lidocaine).	  A	  
double	  blinded	  study,	  such	  as	  this	  one,	  eliminates	  bias	  of	  the	  investigator	  and	  the	  participant.	  
Neither	  will	  be	  bias	  of	  the	  result	  and	  thus,	  unable	  to	  consciously	  or	  subconsciously	  influence	  
experimental	  observations.	  	  
Like	  other	  studies	  that	  measure	  pain	  in	  relation	  to	  an	  intervention,	  this	  study	  used	  a	  
subjective	  method	  to	  assess	  pain.	  Pain	  is	  a	  subjective	  symptom;	  however,	  each	  individual	  has	  a	  
different	  pain	  threshold	  and	  rates	  pain	  differently	  on	  a	  numbered	  scale.	  This	  could	  lead	  to	  
major	  variations	  in	  results.	  An	  objective	  measurement	  of	  pain	  would	  be	  more	  reliable.	  Another	  
issue	  with	  this	  study	  is	  the	  use	  of	  only	  females.	  In	  order	  to	  confidently	  apply	  the	  study	  results	  to	  
the	  general	  population,	  male	  participants	  should	  have	  been	  included.	  Again,	  there	  are	  
considerable	  differences	  in	  pain	  threshold	  and	  reporting	  between	  individuals,	  and	  especially	  
between	  males	  and	  females.	  What	  may	  be	  beneficial	  to	  a	  female	  population	  may	  not	  be	  for	  a	  






	  	  	  	  	  	  	  	   To	  summarize,	  ethyl	  chloride	  administration	  was	  shown	  to	  provide	  statistically	  
significant	  benefit	  for	  females	  receiving	  forehead	  BTX	  injections	  (p<0.005)	  and	  females	  
receiving	  propofol	  injections	  prior	  to	  surgery	  (p<0.001),	  but	  this	  significance	  was	  not	  shown	  for	  
a	  study	  of	  males	  and	  females	  receiving	  various	  hand	  injections.1-­‐3	  These	  conclusions	  were	  
reached	  after	  scanning	  the	  literature	  for	  articles	  comparing	  ethyl	  chloride	  with	  a	  control	  and	  
reviewing	  these	  three	  selected	  articles.	  Furthermore,	  there	  is	  conflicting	  and	  insufficient	  data	  to	  
make	  a	  sweeping,	  evidence-­‐based	  recommendation	  to	  endorse	  the	  use	  of	  ethyl	  chloride	  for	  the	  
general	  population	  and	  the	  majority	  of	  injections	  due	  to	  the	  narrow	  scope	  of	  these	  studies.	  The	  
studies	  vary	  in	  numerous	  areas	  including,	  but	  not	  limited	  to,	  their	  methods,	  measurements	  of	  
treatment	  endpoints,	  injection	  types,	  and	  populations	  studied.	  These	  variations	  confound	  
results.	  This	  limits	  analysis	  and	  the	  ability	  to	  compare	  their	  results	  for	  the	  purpose	  of	  drawing	  
more	  general	  conclusions	  about	  the	  efficacy	  of	  ethyl	  chloride.	  Finding	  more	  homogenous	  and	  
broad	  data	  on	  this	  topic	  was	  difficult	  as	  additional	  studies	  scanned	  were	  frequently	  examining	  
ethyl	  chloride	  only	  in	  comparison	  to	  other	  analgesics	  as	  opposed	  to	  placebo	  or	  no	  treatment	  
controls.	  Ethyl	  chloride	  compared	  to	  other	  analgesics	  is	  outside	  the	  scope	  of	  this	  review.	  
Additionally,	  each	  study	  has	  its	  own	  limitations,	  differing	  levels	  of	  reliability,	  and	  varying	  levels	  
of	  bias	  toward	  a	  specific	  recommendation.	  
	  	  	  	  	  	  	  	   Study	  one	  is	  limited	  by	  its	  focus	  exclusively	  on	  the	  hand	  as	  an	  injection	  site.1	  The	  hand’s	  
specific	  anatomy	  and	  syndromes	  make	  it	  difficult	  to	  compare	  to	  injections	  of	  other	  anatomic	  
locations.	  Additionally,	  it	  is	  limited	  by	  the	  fact	  that	  patients	  who	  requested	  ethyl	  chloride	  
administration	  were	  excluded.	  This	  limits	  the	  population	  of	  study	  to	  those	  naïve	  to	  ethyl	  
chloride	  spray.	  This	  is	  excluding	  a	  group	  that	  has	  potentially	  received	  benefit	  from	  it	  previously.	  
This	  population	  exclusion,	  as	  well	  as	  not	  addressing	  whether	  those	  that	  requested	  to	  not	  
receive	  ethyl	  chloride	  spray	  were	  included,	  creates	  doubts	  about	  the	  reliability	  of	  the	  study	  
results.1	  This	  exclusion	  of	  one	  population	  that	  presumably	  experiences	  benefit	  from	  ethyl	  
chloride	  and	  not	  one	  that	  had	  a	  negative	  experience	  with	  in	  the	  past	  is	  concerning	  for	  bias	  
toward	  ethyl	  chloride	  not	  being	  an	  effective	  analgesia.	  This	  potential	  bias	  is	  consistent	  with	  the	  
conclusion	  of	  the	  study,	  which	  states	  that	  no	  statistically	  significant	  benefit	  was	  discovered	  with	  
ethyl	  chloride	  usage.1	  Furthermore,	  the	  study	  is	  limited	  by	  admitted	  lack	  of	  blinding	  by	  patients	  
and	  observers	  to	  the	  mechanism	  of	  treatment.1	  A	  lack	  of	  blinding	  is	  concerning	  for	  creating	  a	  
bias	  in	  pain	  reporting	  and	  interpretation	  of	  results.1	  There	  are	  no	  conflicts	  of	  interest	  noted.1	  
	  	  	  	  	  	  	  	   Study	  two	  is	  limited	  as	  it	  was	  completed	  with	  a	  population	  of	  a	  small	  group	  of	  only	  
females.2	  The	  population	  of	  the	  study	  was	  limited	  to	  45	  participants	  in	  total.2	  Increasing	  the	  
sample	  size	  and	  with	  a	  similar	  amount	  of	  men	  and	  women	  would	  more	  accurately	  represent	  a	  
typical	  population	  and	  allow	  for	  drawing	  broader	  conclusions	  from	  the	  research.	  The	  study	  was	  
limited	  exclusively	  to	  BTX	  injections	  of	  the	  forehead	  as	  well.2	  This	  limits	  not	  just	  the	  site	  that	  
conclusions	  can	  be	  extrapolated	  from,	  but	  also	  the	  types	  of	  injection	  needles	  utilized,	  as	  only	  
those	  suitable	  for	  forehead	  BTX	  injections	  are	  being	  studied.2	  Similar	  to	  study	  one,	  the	  patients	  
were	  not	  blinded	  to	  their	  treatment	  as	  the	  effects	  of	  a	  cooling	  spray	  could	  not	  be	  easily	  
replicated.2	  The	  knowledge	  of	  treatment	  by	  the	  patient,	  observer,	  and	  provider	  can	  create	  bias	  
and	  concerns	  about	  the	  reliability	  of	  pain	  reported.2	  Those	  with	  a	  desire	  for	  a	  treatment	  to	  
work	  or	  not	  to	  work	  can	  alter	  the	  results	  of	  the	  study	  if	  they	  have	  the	  knowledge	  that	  they	  are	  
or	  are	  not	  receiving	  the	  treatment.	  Results	  consisting	  exclusively	  of	  subjective	  data,	  such	  as	  in	  
this	  study	  and	  study	  one,	  are	  more	  prone	  to	  such	  bias	  and	  can	  skew	  the	  results.1,2	  There	  are	  no	  
conflicts	  of	  interest	  noted.2	  
	  	  	  	  	  	  	  	   Study	  three,	  similar	  to	  the	  aforementioned	  studies,	  is	  limited	  by	  the	  need	  to	  measure	  
pain	  subjectively.3	  Due	  to	  varying	  pain	  thresholds	  among	  patients	  and	  their	  correlation	  
between	  specific	  pain	  perceived	  to	  the	  scale	  in	  the	  study,	  there	  is	  likely	  great	  variability	  to	  the	  
study	  results.3	  Like	  study	  two,	  this	  study	  used	  an	  exclusively	  female	  population	  and	  therefore	  
cannot	  be	  extrapolated	  to	  the	  general	  population.3	  No	  conflicts	  of	  interest	  were	  noted.3	  
	  	  	  	  	  	  	  	   Overall,	  this	  review	  is	  weakened	  by	  a	  lack	  of	  available	  studies	  with	  large,	  diverse	  sample	  
sizes	  that	  have	  various	  injection	  sites	  studied.	  Two	  out	  of	  three	  studies	  were	  limited	  by	  sample	  
size	  and	  population	  studied,	  but	  all	  three	  were	  limited	  in	  scope	  to	  a	  specific	  type	  of	  injection.1-­‐3	  
Therefore,	  these	  studies	  are	  unable	  to	  contribute	  sufficient	  evidence	  to	  support	  ethyl	  chloride	  
as	  clearly	  providing	  clinically	  significant	  analgesia	  for	  the	  general	  population	  for	  all,	  or	  even	  
most,	  injection	  types.	  However,	  statistically	  significant	  results	  were	  found	  in	  studies	  two	  
(p<0.005)	  and	  three	  (p<0.001)	  showing	  that	  for	  their	  female	  population	  studied	  ethyl	  chloride	  
provided	  pain	  reduction	  for	  forehead	  BTX	  and	  upper	  arm	  propofol	  injections.2,3	  There	  are	  no	  




	   Injection	  fear	  plays	  a	  major	  role	  in	  whether	  a	  patient	  receives	  appropriate	  care	  and	  
treatment.	  Diminishing	  or	  eliminating	  pain	  with	  injections	  helps	  build	  good	  rapport	  with	  
patients	  and	  can	  reduce	  a	  major	  barrier	  to	  treatment.	  Since	  injections	  occur	  in	  all	  areas	  of	  
healthcare,	  many	  methods	  of	  analgesia	  have	  been	  studied.	  	  
Ethyl	  chloride	  spray	  may	  be	  a	  promising	  method	  of	  analgesia	  due	  to	  its	  quick	  onset	  of	  
action,	  ease	  of	  use,	  and	  good	  safety	  profile.	  However,	  in	  this	  review,	  we	  cannot	  conclude	  that	  
ethyl	  chloride	  spray	  is	  an	  effective	  analgesic	  prior	  to	  all	  injections	  in	  both	  men	  and	  women	  due	  
to	  the	  differences	  in	  conclusions	  and	  variations	  between	  each	  study.	  The	  narrow	  scope	  of	  
studied	  injection	  types	  and	  sites	  limit	  our	  recommendations	  for	  ethyl	  chloride	  spray	  use.	  We	  do	  
recommend	  its	  use	  prior	  to	  BTX	  forehead	  injections	  and	  dorsal	  hand	  propofol	  injections	  in	  
women	  age	  18	  and	  older,	  based	  on	  results	  from	  Irkoren	  et	  al.	  and	  Moon	  et	  al.2,3	  
Futures	  studies	  should	  be	  performed	  on	  a	  large	  population	  size	  that	  includes	  both	  men	  
and	  women	  in	  order	  for	  conclusions	  to	  be	  drawn	  about	  the	  analgesic	  effect	  of	  ethyl	  chloride	  in	  
the	  general	  population.	  Studies	  should	  also	  attempt	  to	  observe	  objective	  measurements	  of	  pain	  
to	  assess	  efficacy	  of	  ethyl	  chloride	  spray.	  This	  would	  be	  beneficial	  as	  individual	  pain	  thresholds	  
and	  scoring	  of	  pain	  differs.	  Objective	  measurements	  of	  pain	  will	  provide	  accurate	  data	  free	  of	  
subjective	  variation.	  Lastly,	  it	  would	  be	  beneficial	  for	  studies	  to	  assess	  ethyl	  chloride	  spray	  in	  a	  
variety	  of	  injection	  locations.	  Innervation	  differs	  in	  varying	  regions	  of	  the	  body	  which	  makes	  it	  
difficult	  to	  conclude	  that	  ethyl	  chloride	  spray	  is	  effective	  everywhere.	  Ideally,	  studies	  would	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